DE68913383D1 - Rinderfaktor-Xa-hemmender Faktor und diesen enthaltende pharmazeutische Zusammensetzungen. - Google Patents

Rinderfaktor-Xa-hemmender Faktor und diesen enthaltende pharmazeutische Zusammensetzungen.

Info

Publication number
DE68913383D1
DE68913383D1 DE89306345T DE68913383T DE68913383D1 DE 68913383 D1 DE68913383 D1 DE 68913383D1 DE 89306345 T DE89306345 T DE 89306345T DE 68913383 T DE68913383 T DE 68913383T DE 68913383 D1 DE68913383 D1 DE 68913383D1
Authority
DE
Germany
Prior art keywords
factor
pharmaceutical compositions
compositions containing
bovine
inhibitory
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE89306345T
Other languages
English (en)
Other versions
DE68913383T2 (de
Inventor
Meir Rigbi
Craig Jackson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yissum Research Development Co of Hebrew University of Jerusalem
American National Red Cross
Original Assignee
Yissum Research Development Co of Hebrew University of Jerusalem
American National Red Cross
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yissum Research Development Co of Hebrew University of Jerusalem, American National Red Cross filed Critical Yissum Research Development Co of Hebrew University of Jerusalem
Application granted granted Critical
Publication of DE68913383D1 publication Critical patent/DE68913383D1/de
Publication of DE68913383T2 publication Critical patent/DE68913383T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/855—Proteins from animals other than mammals or birds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE68913383T 1988-06-24 1989-06-23 Rinderfaktor-Xa-hemmender Faktor und diesen enthaltende pharmazeutische Zusammensetzungen. Expired - Fee Related DE68913383T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL86856A IL86856A0 (en) 1988-06-24 1988-06-24 Bovine xa factor and pharmaceutical compositions containing the same

Publications (2)

Publication Number Publication Date
DE68913383D1 true DE68913383D1 (de) 1994-04-07
DE68913383T2 DE68913383T2 (de) 1994-07-14

Family

ID=11058977

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68913383T Expired - Fee Related DE68913383T2 (de) 1988-06-24 1989-06-23 Rinderfaktor-Xa-hemmender Faktor und diesen enthaltende pharmazeutische Zusammensetzungen.

Country Status (8)

Country Link
US (2) US5182113A (de)
EP (1) EP0352903B1 (de)
JP (1) JP3176604B2 (de)
AT (1) ATE102039T1 (de)
DE (1) DE68913383T2 (de)
ES (1) ES2052916T3 (de)
HK (1) HK182296A (de)
IL (1) IL86856A0 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4001238A1 (de) * 1990-01-18 1991-07-25 Basf Ag Verfahren zur anreicherung bzw. reinigung von biomolekuelen
CA2047527A1 (en) * 1990-07-24 1992-01-25 Christopher Dunwiddie Method for administering a therapeutic anticoagulant
GB9022040D0 (en) * 1990-10-10 1990-11-21 Biopharm Ltd Platelet adhesion inhibitor
DE4234921A1 (de) * 1992-10-16 1994-04-21 Basf Ag Neues, die Gerinnungszeit des Blutes verlängerndes Protein aus dem Landblutegel Haemadipsa sylestris
US5824641A (en) * 1993-04-09 1998-10-20 Bio-Technology General Corp Method of treating of preventing influenza
ATE198710T1 (de) * 1993-04-09 2001-02-15 Bio Technology General Corp Neuartiges polypeptid mit einer inhibierenden aktivität gegen faktor xa
DE69429858D1 (de) * 1993-04-09 2002-03-21 Bio Technology General Corp Herstellung eines rekombinanten inhibitors des faktors xa des blutegels hirudo medicinalis
CA2143416C (en) * 1993-07-01 2003-06-10 Jurgen Hemberger Inhibitor of collagen-stimulated platelet aggregation
DE4440892A1 (de) * 1994-11-17 1996-05-23 Gruenenthal Gmbh Proteine mit fibrinolytischen und gerinnungshemmenden Eigenschaften
US6046169A (en) * 1995-06-07 2000-04-04 Cor Therapeutics, Inc. Inhibitors of factor XA
US5721214A (en) * 1995-06-07 1998-02-24 Cor Therapeutics, Inc. Inhibitors of factor Xa
US6069130A (en) 1995-06-07 2000-05-30 Cor Therapeutics, Inc. Ketoheterocyclic inhibitors of factor Xa
US5919765A (en) * 1995-06-07 1999-07-06 Cor Therapeutics, Inc. Inhibitors of factor XA
US6022861A (en) * 1995-06-07 2000-02-08 Cor Therapeutics, Inc. Ketoheterocyclic inhibitors of factor Xa
US6245743B1 (en) 1996-06-05 2001-06-12 Cor Therapeutics, Inc. Inhibitors of factor Xa
US6194435B1 (en) 1996-10-11 2001-02-27 Cor Therapeutics, Inc. Lactams as selective factor Xa inhibitors
US6063794A (en) 1996-10-11 2000-05-16 Cor Therapeutics Inc. Selective factor Xa inhibitors
US6262047B1 (en) 1996-10-11 2001-07-17 Cor Therapeutics, Inc. Selective factor Xa inhibitors
US6369080B2 (en) 1996-10-11 2002-04-09 Cor Therapeutics, Inc. Selective factor Xa inhibitors
WO1998046626A1 (en) 1997-04-14 1998-10-22 Cor Therapeutics, Inc. SELECTIVE FACTOR Xa INHIBITORS
US6133256A (en) * 1997-04-14 2000-10-17 Cor Therapeutics Inc Selective factor Xa inhibitors
WO1998046627A1 (en) 1997-04-14 1998-10-22 Cor Therapeutics, Inc. SELECTIVE FACTOR Xa INHIBITORS
US6228854B1 (en) 1997-08-11 2001-05-08 Cor Therapeutics, Inc. Selective factor Xa inhibitors
US6218382B1 (en) 1997-08-11 2001-04-17 Cor Therapeutics, Inc Selective factor Xa inhibitors
US6333321B1 (en) 1997-08-11 2001-12-25 Cor Therapeutics, Inc. Selective factor Xa inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4588587A (en) * 1983-03-01 1986-05-13 Pennsylvania Hospital Method of treatment to inhibit metastasis
EP0209061B1 (de) * 1985-07-17 1994-01-12 Hoechst Aktiengesellschaft Neue Polypeptide mit blutgerinnungshemmender Wirkung, Verfahren zu deren Herstellung bzw. Gewinnung, deren Verwendung und diese enthaltende Mittel
ZA876998B (en) * 1986-09-18 1989-05-30 Contributors To The Pennsylvan Protein having anticoagulant and antimetastatic properties
US4832849A (en) * 1988-06-16 1989-05-23 Merrell Dow Pharmaceuticals Inc. Extraction and purification of an anticoagulant principle from the south american leech, haementeria ghilianii

Also Published As

Publication number Publication date
JP3176604B2 (ja) 2001-06-18
EP0352903A3 (en) 1990-06-13
DE68913383T2 (de) 1994-07-14
US5403596A (en) 1995-04-04
EP0352903B1 (de) 1994-03-02
HK182296A (en) 1996-10-11
IL86856A0 (en) 1988-11-30
ATE102039T1 (de) 1994-03-15
US5182113A (en) 1993-01-26
EP0352903A2 (de) 1990-01-31
JPH02111800A (ja) 1990-04-24
ES2052916T3 (es) 1994-07-16

Similar Documents

Publication Publication Date Title
DE68913383D1 (de) Rinderfaktor-Xa-hemmender Faktor und diesen enthaltende pharmazeutische Zusammensetzungen.
IL89835A0 (en) Substituted azetidinones,their preparation and pharmaceutical compositions containing them
ATE243196T1 (de) Piperidine und pyrrolidine
FI892454A0 (fi) Nya bensimidazolderivat, foerfarande foer framstaellning av desamma och farmaceutisk komposition innehaollande desamma.
ATE100098T1 (de) Nukleoside, ihre herstellung und pharmazeutische zusammenstellungen.
FI903759A0 (fi) Farmaceutisk komposition innehaollande n-acetylcystein foer oral administrering.
IT8820386A0 (it) Composizioni farmaceutiche orosolubili contenti acetilcisteina.
AU3885689A (en) Selectively o-acylated glycosaminoglycans, their preparation and pharmaceutical compositions containing them
UA41332C2 (uk) Білок, здатний інгібувати стимульовану колагеном агрегацію тромбоцитів, спосіб його одержання, фармацевтичний препарат, спосіб обробки імплантованого або екстракорпорального медичного пристрою та спосіб одержання лікарського засобу
DE59208622D1 (de) Dentalwerkstoffe auf Basis von (Meth)-Acrylaten
ATA30594A (de) Gereinigte form von streptograminen, ihre herstellung und sie enthaltende pharmazeutische massen
DE68911166D1 (de) Baukasten zur Herstellung von Blisterverpackungen.
IT8819731A0 (it) Composizioni farmaceutiche contenenti timosina alfa 1.
IL106289A0 (en) Phospholipid derivatives, their preparation and pharmaceutical compositions containing them
DE69521315T2 (de) Hirudin enthaltende pharmazeutische zusammensetzungen
DE68907609D1 (de) Arzneimittelzusammensetzung.
IL70990A0 (en) Pharmaceutical compositions containing glyceryl mononitrates
ATE145824T1 (de) Aerosolformulierung enthaltend fusafungin
ATE78161T1 (de) 4-aroylimidazol-2-on enthaltende pharmazeutische zusammensetzung.
EP0098475A3 (de) Pharmazeutische Zusammensetzung, ihre Herstellung und Verwendung
IL89015A (en) Pharmaceutical compositions containing tetrahydropyridine derivatives, certain such novel compounds and their preparation
IT8622051A0 (it) Composizioni farmaceutiche adattivita' cicatrizzante.
NO910071L (no) Polymersammensetning for fjerning av oksygen.
ATE74767T1 (de) Arzneimittelzusammensetzung zur behandlung des lungenverstopfens.
ATE97574T1 (de) Arzneimittelzusammensetzung, enthaltend deoxyribonukleoside fuer heilung von wunden.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee